14.07.2018 - 08:06 Uhr

Apotex Focuses on High Growth Markets with Sale of European Generics Business

Sale Part of Previously Announced Plan to Assess Global Footprint TORONTO, July 14, 2018 /CNW/ - Apotex, Canada's largest generic pharmaceutical company, has signed an agreement...

Den vollständigen Artikel auf finanzen.ch lesen.